D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 104 Citations 49,958 838 World Ranking 4112 National Ranking 121

Overview

What is he best known for?

The fields of study Christopher C. Rowe is best known for:

  • Alzheimer's disease
  • Dementia
  • Magnetic resonance imaging

His studies link Cognitive decline with Disease. With his scientific publications, his incorporates both Alzheimer's disease and Episodic memory. Borrowing concepts from Cognition, Christopher C. Rowe weaves in ideas under Episodic memory. He carries out multidisciplinary research, doing studies in Cognition and Neuropsychology. He undertakes multidisciplinary investigations into Neuropsychology and Dementia in his work. Christopher C. Rowe carries out multidisciplinary research, doing studies in Dementia and Frontotemporal dementia. Pathology connects with themes related to Amyloid (mycology) in his study. His study ties his expertise on Pathology together with the subject of Amyloid (mycology). In his study, Christopher C. Rowe carries out multidisciplinary Internal medicine and Oncology research.

His most cited work include:

  • Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (5289 citations)
  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria (2376 citations)
  • Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study (1594 citations)

What are the main themes of his work throughout his whole career to date

Cognitive decline and Pittsburgh compound B are the two main areas of interest in his Dementia studies. He is exploring Cognition as part of his Episodic memory, Cognitive impairment and Neuropsychology and Cognition studies. Christopher C. Rowe performs multidisciplinary study in the fields of Episodic memory and Alzheimer's disease via his papers. In his articles, Christopher C. Rowe combines various disciplines, including Alzheimer's disease and Pittsburgh compound B. As part of his studies on Cognitive impairment, he often connects relevant areas like Disease. His Disease study frequently links to adjacent areas such as Cognitive decline. In his works, Christopher C. Rowe performs multidisciplinary study on Neuropsychology and Dementia. In the field of Neuroimaging Christopher C. Rowe connects related research areas like Neuroscience and Psychiatry. He undertakes multidisciplinary studies into Neuroscience and Cognition in his work.

Christopher C. Rowe most often published in these fields:

  • Disease (77.95%)
  • Internal medicine (64.17%)
  • Dementia (57.09%)

What were the highlights of his more recent work (between 2020-2022)?

  • Internal medicine (82.35%)
  • Disease (70.59%)
  • Dementia (58.82%)

In recent works Christopher C. Rowe was focusing on the following fields of study:

By researching both Internal medicine and Endocrinology, Christopher C. Rowe produces research that crosses academic boundaries. He connects Endocrinology with Internal medicine in his research. Christopher C. Rowe regularly ties together related areas like Neurodegeneration in his Disease studies. His work on Disease expands to the thematically related Neurodegeneration. His study on Dementia is mostly dedicated to connecting different topics, such as Cognitive decline. Cognitive decline connects with themes related to Dementia in his study. With his scientific publications, his incorporates both Nuclear medicine and Positron emission tomography. Christopher C. Rowe integrates many fields in his works, including Positron emission tomography and Radiology. Christopher C. Rowe undertakes interdisciplinary study in the fields of Radiology and Nuclear medicine through his works.

Between 2020 and 2022, his most popular works were:

  • Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum (48 citations)
  • Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer’s Disease (42 citations)
  • Advances in Brain Amyloid Imaging (22 citations)

In his most recent research, the most cited works focused on:

  • Alzheimer's disease
  • Hippocampus
  • Central nervous system

His Cohort study research includes a combination of various areas of study, such as Prospective cohort study and Cohort. He connects Cohort with Cohort study in his research. His research combines Prospective cohort study and Internal medicine. His study connects Cognitive decline and Disease. His Cognitive decline study frequently draws connections between related disciplines such as Dementia. In his works, he performs multidisciplinary study on Dementia and Cognition. He integrates Cognition and Alzheimer's disease in his studies. By researching both Alzheimer's disease and Biomarker, he produces research that crosses academic boundaries. Many of his studies on Biomarker involve topics that are commonly interrelated, such as Biochemistry.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Reisa A. Sperling;Paul S. Aisen;Laurel A. Beckett;David A. Bennett.
Alzheimers & Dementia (2011)

4881 Citations

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo.
Alzheimers & Dementia (2018)

4410 Citations

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)

2859 Citations

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Victor L. Villemagne;Samantha Burnham;Pierrick Bourgeat;Belinda M. Brown.
Lancet Neurology (2013)

1770 Citations

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

Bruno Dubois;Harald Hampel;Harald Hampel;Howard H. Feldman;Philip Scheltens.
Alzheimers & Dementia (2016)

1218 Citations

Imaging beta-amyloid burden in aging and dementia.

Christopher C Rowe;Steven Ng;Uwe Ackermann;Sylvia Gong.
Neurology (2007)

1206 Citations

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

Christopher C Rowe;Kathryn A Ellis;Kathryn A Ellis;Miroslava Rimajova;Pierrick Bourgeat.
Neurobiology of Aging (2010)

1013 Citations

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

Akinori Nakamura;Naoki Kaneko;Victor L Villemagne;Takashi Kato.
Nature (2018)

993 Citations

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Kerryn Elizabeth Pike;Gregory Raymond Savage;Victor L Villemagne;Steven Ng.
Brain (2007)

908 Citations

Longitudinal Assessment of Aβ and Cognition in Aging and Alzheimer Disease

Victor L Villemagne;Kerryn E Pike;Gaël Chételat;Kathryn A Ellis.
Annals of Neurology (2011)

861 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Christopher C. Rowe

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 524

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 466

Reisa A. Sperling

Reisa A. Sperling

Brigham and Women's Hospital

Publications: 299

William J. Jagust

William J. Jagust

University of California, Berkeley

Publications: 248

Philip Scheltens

Philip Scheltens

Amsterdam UMC

Publications: 241

Clifford R. Jack

Clifford R. Jack

Mayo Clinic

Publications: 222

Ronald C. Petersen

Ronald C. Petersen

Mayo Clinic

Publications: 213

Alzheimer's Disease Neuroimaging Initiative

Alzheimer's Disease Neuroimaging Initiative

University of North Carolina at Chapel Hill

Publications: 212

Keith A. Johnson

Keith A. Johnson

Harvard University

Publications: 206

John C. Morris

John C. Morris

Washington University in St. Louis

Publications: 197

Pieter Jelle Visser

Pieter Jelle Visser

Amsterdam University Medical Centers

Publications: 192

Giovanni B. Frisoni

Giovanni B. Frisoni

University of Geneva

Publications: 187

Gil D. Rabinovici

Gil D. Rabinovici

University of California, San Francisco

Publications: 173

David S. Knopman

David S. Knopman

Mayo Clinic

Publications: 171

Frederik Barkhof

Frederik Barkhof

University College London

Publications: 161

Ralph N. Martins

Ralph N. Martins

Edith Cowan University

Publications: 161

Trending Scientists

George C. Polyzos

George C. Polyzos

Athens University of Economics and Business

Javier Ramírez

Javier Ramírez

University of Granada

Ignacio Carol

Ignacio Carol

Universitat Politècnica de Catalunya

Zempachi Ogumi

Zempachi Ogumi

Kyoto University

Huige Wei

Huige Wei

Tianjin University of Science and Technology

Wolfgang Peukert

Wolfgang Peukert

University of Erlangen-Nuremberg

P. A. Joy

P. A. Joy

Council of Scientific and Industrial Research

David Bentley

David Bentley

University of Colorado Denver

Gábor L. Lövei

Gábor L. Lövei

Aarhus University

Jean-Marc Ghigo

Jean-Marc Ghigo

Université Paris Cité

Punnee Pitisuttithum

Punnee Pitisuttithum

Mahidol University

Carol E. Franz

Carol E. Franz

University of California, San Diego

Bennett J. Tepper

Bennett J. Tepper

The Ohio State University

Zuo-Feng Zhang

Zuo-Feng Zhang

University of California, Los Angeles

Jennifer D. Davis

Jennifer D. Davis

Brown University

Alfred Vidal-Madjar

Alfred Vidal-Madjar

Institut d'Astrophysique de Paris

Something went wrong. Please try again later.